T. Moriarty Aly Farag, S. Y., A. M. Eldeib, and S. Hushek,
"Interactive Visualization and Volume Registration by Surface Point Signature and Mutual Information Maximization with Applications in Intra-operative MRI Surgeries",
Third International Conference MICCAI, Pittsburgh, PA, USA, October 11-14, 2, 2000.
and T.A.Yehia, R.G.Stino, E. S. H. A. A. H.,
"Mathematical estimation of fruit set types and degrees of compatibility in Anna apples",
Proceeding of 1 St Congress on Recent Technologies In Agriculture, Cairo university , Faculty of Agriculture 27-29 November, 1999, vol. 1, pp. 13-17, 1999.
Abstractn/a
and T.A.Yehia, E.S.Hegazi, R. G. S. A. A. H.,
"Effect of pollination type on fruiting of Anna apples. 2- Embryo development and fruit seed content",
Proceeding of 1 St Congress on Recent Technologies In Agriculture, Cairo university , Faculty of Agriculture 27-29 November, 1999, vol. 1, pp. 8-12, 1999.
Abstractn/a
T.Abdel-Aziz, M. S., A.L.Aboul-Nasr, S.M.Sharawi, and H.A.Basha,
"Plasma atrial natriuretic peptide concentration in severe preeclampsia treated with magnesium sulfate. ",
Med. J. Cairo Univ., vol. 58, issue 4, pp. 65-75, 1990.
T.Khayyal, M., A. M.Agha, H. F.Zaki, A. El-Sahar, and H. Abdel-Aziz,
"Mechanisms Involved in the Anti-inflammatory and Vascular Effect of Iberis amara Extract",
Planta medica, vol. 81, issue 12, pp. 1097-1102, 2015.
T.Manie, A.Farahat, T.Hashem, M.M.G.Youssef, A.R.Abdalwahab, I.Elattar, and T.S.El-Baradie,
"Preoperative estimation of cosmetic outcomesafter immediate breast reconstruction withextended latissimus dorsi flap: A simpleprediction model",
JPRAS Open, vol. 15, pp. 10-17, 2018.
T.Sharaf, E. L. M. Shibini, Z. H. Osman, and P. Groumpos,
"The Reserve Constrained Optimal Load Flow as Applied to The Integrated Electric Grid of Egypt",
Modeling , Simulation, and Control, vol. 25, issue 1, pp. 1-14, 1989.
TA, G., E. - F. HS, N. MM, and H. H,
"Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions",
Int J Rheum Dis, vol. 15, issue 6, pp. 521-5, 2012.
AbstractOBJECTIVES:
To verify the relation of gout to insulin resistance (IR) and metabolic syndrome (MetS) and find any association of metatarsophalangeal (MTP) joint erosions to the features of MetS and IR.
METHODS:
Forty-six primary gout male patients with a mean age of 41.96 ± 5.77 years were grouped according to the presence of MetS. Twenty-seven age and sex matched healthy volunteers served as controls. Insulin sensitivity was estimated using the homeostatic model assessment index (HOMA-B) for beta cell function and HOMA-IR for peripheral tissue IR.
RESULTS:
Gout patients had significantly higher HOMA-IR and HOMA-B compared to controls. Those with MetS (n = 27) had significantly higher serum uric acid (SUA) than those without (n = 19; 11.51 ± 3.72 mg/dL vs. 9.15 ± 2.34 mg/dL; P = 0.012). Gout patients with MTP erosions had notable higher insulin levels and more IR as shown by the higher levels of HOMA-IR and HOMA-B compared to those without. HOMA-IR and HOMA-B significantly correlated with the presence of erosions. Moreover, the presence of erosions significantly correlated with SUA (r = 0.64, P < 0.0001).
CONCLUSIONS:
The level of SUA is closely related to IR in patients with and without MetS. There is an association of the severity of gout and presence of MTP erosions to IR. Metabolic syndrome forms an important marker for those who develop more punched-out erosions.
TA, M., and M. MM,
"The effect of glycemic control on visual and anatomic outcomes in response to therapy for diabetic macular edema.",
Eur J Ophthalmol, vol. 23, issue 1, pp. 94-100, 2013.
Abstract
Purpose. To evaluate the effect of glycemic control on response to therapy of diabetic clinically significant macular edema (CSME). Methods. Patients with CSME had their glycosylated hemoglobin (HbA1c) measured at baseline and 6 months. Central foveal thickness (CFT) and best-corrected visual acuity (BCVA) in logMAR were measured at baseline, 3 months, and 6 months. Therapy included laser and intravitreal bevacizumab. HbA1c was graded as G1 <7%, G23 7%–7.9%, G3 8%–8.9%, G4 >9%. Results. Fifty-two eyes were included with mean logMAR BCVA and CFT as follows: baseline 0.75 and 423±106 µm; 3 months 0.47 and 293±69 µm; and 6 months 0.48 and 324±76 µm. Mean HbA1c was 8.13% and 7.43% at baseline and 6 months, respectively. There was no statistically significant difference between baseline and 6 months HbA1c groups and logMAR BCVAs and CFTs at baseline, 3 months, and 6 months. However, there were positive correlations between baseline HbA1c levels and each of baseline logMAR BCVA (p=0.024), baseline CFT (p<0.001), and 6-month logMAR BCVA (p=0.007). Improved HbA1c by 6 months did not show any correlation with logMAR BCVA and CFT at 6 months. Conclusions. Lower HbA1c appeared to be correlated with better visual acuity and lower CFT values at baseline, and also correlated with significantly better vision and nonsignificantly thinner CFT with therapy at 6 months.
] 